* With a dedicated booth in the main exhibition hall, SK pharmteco solidifies its global position...
* The first interim dividend payout after Articles of Incorporation were amended to enable invest...
* Yposkesi, SK pharmteco's clinical and commercial viral vector manufacturing subsidiary for Cell...
* SOCAR Mobility Malaysia, majority owned by SK Inc., to expand its market dominance inSoutheast ...
* SK to spark innovative ideas and identify new business opportunities by presenting its global s...
- SK Inc. evaluated as one of the best ESG leaders by a global ESG evaluator MSCI - The company ha...
- Joerg Ahlgrimm brings 25 years of expertise in pharmaceuticals and innovative cell and gene thera...
* SK Inc. to buyback KRW200 billion worth of its own shares in the next 6 months, marking the fir...
* SK Inc. has decided to pay an interim dividend for fifth consecutive year; Despite uncertaintie...
- All agenda items approved including approval of financial statement for 2021, appointment of dire...
